Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 4 $ 115,781 $ (75,288) $ 40,497
Balance (in shares) at Dec. 31, 2024 35,649      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Options exercised   485   485
Options exercised (in shares) 327      
Stock-based compensation   575   575
Cancellation of performance-based shares   (792)   (792)
Net loss     (9,765) (9,765)
Balance at Mar. 31, 2025 $ 4 116,049 (85,053) 31,000
Balance (in shares) at Mar. 31, 2025 35,976      
Balance at Dec. 31, 2024 $ 4 115,781 (75,288) 40,497
Balance (in shares) at Dec. 31, 2024 35,649      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (20,148)
Balance at Jun. 30, 2025 $ 4 116,643 (95,436) 21,211
Balance (in shares) at Jun. 30, 2025 36,111      
Balance at Mar. 31, 2025 $ 4 116,049 (85,053) 31,000
Balance (in shares) at Mar. 31, 2025 35,976      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stocks vested (in shares) 135      
Stock-based compensation   594   594
Net loss     (10,383) (10,383)
Balance at Jun. 30, 2025 $ 4 116,643 (95,436) 21,211
Balance (in shares) at Jun. 30, 2025 36,111      
Balance at Dec. 31, 2025 $ 4 118,019 (115,485) 2,538
Balance (in shares) at Dec. 31, 2025 36,131      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock on options exercised and restricted stocks vested   95   95
Issuance of stock on options exercised and restricted stocks vested (in shares) 99      
Stock-based compensation   526   526
Cancellation of performance-based shares   (321)   (321)
Tax withholding on vesting and exercise of equity awards   (38)   (38)
Net loss     (8,150) (8,150)
Balance at Mar. 31, 2026 $ 4 118,281 (123,635) (5,350)
Balance (in shares) at Mar. 31, 2026 36,230      
Balance at Dec. 31, 2025 $ 4 118,019 (115,485) 2,538
Balance (in shares) at Dec. 31, 2025 36,131      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (16,844)
Balance at Jun. 30, 2026 $ 4 118,994 (132,329) (13,331)
Balance (in shares) at Jun. 30, 2026 36,634      
Balance at Mar. 31, 2026 $ 4 118,281 (123,635) (5,350)
Balance (in shares) at Mar. 31, 2026 36,230      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock on options exercised and restricted stocks vested   157   157
Issuance of stock on options exercised and restricted stocks vested (in shares) 404      
Stock-based compensation   602   602
Tax withholding on vesting and exercise of equity awards   (46)   (46)
Net loss     (8,694) (8,694)
Balance at Jun. 30, 2026 $ 4 $ 118,994 $ (132,329) $ (13,331)
Balance (in shares) at Jun. 30, 2026 36,634